Scala Biodesign

Scala BiodesignScala Biodesign
Scala Biodesign

Scala Biodesign

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

2021Active30
Rate

About

Scala Biodesign leverages a unique computational platform that integrates evolutionary analysis, atomistic protein design calculations, and artificial intelligence to engineer proteins with enhanced properties. These custom-designed proteins are intended for applications in the pharmaceutical, chemical, and sustainability sectors, aiming to accelerate the development of commercial products.

Technology stack

detected 2026-06-27
EmailGoogle Workspace
Stack
Wix
Analytics
LinkedIn Insight Tag
Observability
Sentry
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Scala Biodesign do?

Scala Biodesign leverages a unique computational platform that integrates evolutionary analysis, atomistic protein design calculations, and artificial intelligence to engineer proteins with enhanced properties. These custom-designed proteins are intended for applications in the pharmaceutical, chemical, and sustainability sectors, aiming to accelerate the development of commercial products.

How much funding has Scala Biodesign raised?

Scala Biodesign has raised a total of $22M in funding. The most recent round on record is Series A.

Where is Scala Biodesign headquartered?

Scala Biodesign is headquartered in Tel Aviv, Israel.

When was Scala Biodesign founded?

Scala Biodesign was founded in 2021.

What industry does Scala Biodesign operate in?

Scala Biodesign operates in Life Sciences, Biotech, Protein, AI-Driven Protein Design, Drug Discovery, Computational Biology.

How many employees does Scala Biodesign have?

Scala Biodesign has approximately 30 people on record.